NovaGo Logo


NovaGo’s business strategy is to advance the development of drug candidates through preclinical and early clinical phases and partner its products with leading pharmaceutical and biotech companies for later-stage development and marketing.

Our in-depth know-how in R&D and existing international networks across academia and industry enable the rapid advancement of our programs from discovery through preclinical stages to clinical development. We are interested in partnerships with organizations that provide complimentary expertise and resources to maximize the commercial value of our drug candidates.

For further information on investment or partnering opportunities, please contact us at: